Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system

Muller, Marie-Eve ; Forni Ogna, Valentina ; Maillard, Marc ; Stoudmann, Candice ; Zweiacker, Carole ; Anex, Christiane ; Wuerzner, Grégoire ; Burnier, Michel ; Bonny, Olivier

In: Pflügers Archiv - European Journal of Physiology, 2015, vol. 467, no. 12, p. 2413-2421

Add to personal list
    Interactions between sodium and calcium regulating systems are poorly characterized but clinically important. Parathyroid hormone (PTH) levels are increased shortly after furosemide treatment by an unknown mechanism, and this effect is blunted by the previous administration of a calcimimetic in animal studies. Here, we explored further the possible underlying mechanisms of this observation in a randomized crossover placebo-controlled study performed in 18 human males. Volunteers took either cinacalcet (60mg) or placebo and received a 20mg furosemide injection 3h later. Plasma samples were collected at 15-min intervals and analyzed for intact PTH, calcium, sodium, potassium, magnesium, phosphate, plasma renin activity (PRA), and aldosterone up to 6h after furosemide injection. Urinary electrolyte excretion was also monitored. Subjects under placebo presented a sharp increase in PTH levels after furosemide injection. In the presence of cinacalcet, PTH levels were suppressed and marginal increase of PTH was observed. No significant changes in electrolytes and urinary excretion were identified that could explain the furosemide-induced increase in PTH levels. PRA and aldosterone were stimulated by furosemide injection but were not affected by previous cinacalcet ingestion. Expression of NKCC1, but not NKCC2, was found in parathyroid tissue. In conclusion, our results indicate that furosemide acutely stimulates PTH secretion in the absence of any detectable electrolyte changes in healthy adults. A possible direct effect of furosemide on parathyroid gland needs further studies.